Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Annual revenue, net income & balance sheet · SEC EDGAR XBRL data
Revenue (2025)
$4K
Net Income (2025)
$51K
YoY Revenue
-67.4%
Total Assets (2025)
$0
Financial Intelligence · Sprytne.com
Exousia Bio, Inc. (LMMY) reported $4K in revenue for fiscal year 2025. Net income: $51K. Year-over-year revenue growth: -67.4%. Total assets: $0.
Source: SEC EDGAR XBRL — Standardized Financial Data · CIK 0001939937
| Year | Revenue | Net Income |
|---|---|---|
| 2025(latest) | $4K | $51K |
| 2024 | $12K | ($26K) |
| 2023 | $0 | ($56K) |
| 2022 | $0 | ($937) |
| Item | Amount |
|---|---|
| Total Assets | $0 |
| Current Assets | $0 |
| Total Liabilities | $0 |
| Current Liabilities | $0 |
| Stockholders' Equity | $0 |
Exousia Bio, Inc. reported $4K in revenue for fiscal year 2025, according to SEC EDGAR XBRL filings.
Yes. Exousia Bio, Inc. reported a net income of $51K in 2025, indicating profitability.
Exousia Bio, Inc. had total assets of $0 as of fiscal year 2025, per SEC EDGAR filings.
Company Profile
Exousia Bio, Inc.
SEC filings, executives & overview
All Financials
Company Financial Database
6,800+ SEC-reported companies
Source: SEC EDGAR XBRL — CIK 0001939937. Annual financial data from 10-K filings. Values in USD. Fiscal years may differ from calendar years. Data fetched Mar 2026.